YORVIPATH 420 µg/1.4 ml sol inj 4838 µg 2x1 pce

7680698890034 CH-69889 H05AA05 07.99.0.

No images available

Details

Product number
6988903
CPT
-
Packaging group
2 x 1
Unit
Injektor(en), vorgefüllt/Pen
Composition
palopegteriparatidum 4838 µg corresp. teriparatidum 420 µg, acidum succinicum, mannitolum, metacresolum, natrii hydroxidum, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.4 ml corresp. natrium 10.925 mg.

Articles (1)

Yorvipath 420 μg/1.4 ml, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
2 x 1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/12/2025
Patient information leaflet
Français
16/12/2025
Patient information leaflet
Italien
16/12/2025
Professional SmPC
Allemand
16/12/2025
Professional SmPC
Français
16/12/2025
Professional SmPC
Italien
16/12/2025

Detailed composition

Substance Quantity Type Category
palopegteriparatidum
4838.0 UG Substance Wirkstoff (Principe actif)
teriparatidum
420.0 UG Substance WIZUS
acidum succinicum
- Substance HNIDK
mannitolum
- Substance HNIDK
metacresolum
- Substance Konservierungsstoff (Conservateur)
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
10.925 MG Substance HBESI

Authorization holder

Ascendis Pharma Switzerland GmbH

8008 Zürich

Authorization information

Swissmedic authorization number
69889
Drug name
Yorvipath, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
H05AA05
Authorization status
Z
Dispensation category
B
First authorization
09/12/2025
Authorization expiration date
08/12/2030
IT number
07.99.0.
Domain
Human medicine
Field of application
Behandlung des Hypoparathyreoidismus bei Erwachsenen

Packaging details

Description (FR)
YORVIPATH 420 µg/1.4 ml sol inj 4838 µg 2x1 pce
Description (DE)
YORVIPATH 420 µg/1.4 ml Inj Lös 4838 µg 2x1 Stk
Market launch
01/03/2026
Narcotic (BTM)
No

Other packaging sizes

YORVIPATH 168 µg/0.56 ml sol inj 1935 µg 2x1 pce
2 x 1 INJ
View
YORVIPATH 168 µg/0.56 ml sol inj 1935 µg 2 pce
2 INJ
View
YORVIPATH 294 µg/0.98 ml sol inj 3387 µg 2x1 pce
2 x 1 INJ
View
YORVIPATH 294 µg/0.98 ml sol inj 3387 µg 2 pce
2 INJ
View
YORVIPATH 420 µg/1.4 ml sol inj 4838 µg 2 pce
2 INJ
View
Buy us a coffee Explore the data